Xiaojun Xu
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Minimal Residual Disease Quantification by Next-generation Sequencing in Pediatric B-ALL Children Patients Treated With Blinatumomab Consolidation (NCT05837689) | Xiaojun Xu | 2023-04-01 |
Track Xiaojun Xu automatically
Every clearance here is in the API, with alerts when new ones post.